Leuprorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist, also known as an LHRH analogue, which is primarily used in the management of prostate cancer, breast cancer, endometriosis, uterine… Read more















Leuprorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist, also known as an LHRH analogue, which is primarily used in the management of prostate cancer, breast cancer, endometriosis, uterine fibroids, and central precocious puberty. This category provides essential pharmaceutical reference standards, including the active ingredient itself, along with a comprehensive collection of degradation products, related impurities, and stable isotope labelled compounds. These materials are critical for laboratory professionals conducting impurity profiling, method development, and rigorous quality control within pharmaceutical testing environments. By utilizing these precise reference standards, researchers can ensure the accuracy of analytical methods during stability testing and the identification of unknown degradants such as leuprolide dimers and trimers. This collection supports the development and regulatory compliance of therapeutic formulations, ensuring consistent evaluation of drug purity and consistency throughout the drug development lifecycle.